ClinConnect ClinConnect Logo
Search / Trial NCT06386952

To Compare People With T2DM Who Have Double Hump Versus Who do Not Have Double Hump

Launched by DIABETES FOUNDATION, INDIA · Apr 24, 2024

Trial Information

Current as of July 09, 2025

Recruiting

Keywords

ClinConnect Summary

This clinical trial is studying how the presence of a "double hump" in people with Type 2 Diabetes Mellitus (T2DM) may relate to the severity of diabetes-related complications. The researchers believe that those with a double hump, which is a noticeable fat distribution at the back of the neck and upper back, may experience more serious health issues compared to those without this condition. Participants will be recruited from an endocrine outpatient department and will undergo various physical examinations and assessments to identify complications affecting their eyes, nerves, and kidneys, as well as heart-related problems.

To be eligible for this trial, participants should be between 20 and 70 years old, have Type 2 diabetes for up to 30 years, and have a body mass index (BMI) between 25 and 40. The study aims to better understand the link between body shape and health complications in diabetes, and it is open to both men and women. Participants can expect to have their health assessed through physical exams and tests that check for any diabetes-related issues. It’s important to note that individuals with certain health conditions, such as severe alcohol use or heart disease, will not be eligible to take part in this study.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • 1. Patients with T2DM (up to 30 years Duration)
  • 2. Age 20 to 70 years
  • 3. BMI \>25 kg/m² to \>40 kg/m²
  • 4. Gender- Both (Male \& Female)
  • Exclusion Criteria:
  • 1. Alcoholic with Moderate to Severe.
  • 2. BMI \>40 kg/m²
  • 3. Congestive heart disease
  • 4. Positive hepatitis B or hepatitis C, secondary causes of fatty liver (eg. consumption of amiodarone and tamoxifen) and congestive hepatopathy.
  • 5. Severe end organ damage or chronic diseases: renal/hepatic failure, any malignancy, major systemic illness etc.

About Diabetes Foundation, India

The Diabetes Foundation, India is a leading non-profit organization dedicated to advancing research, education, and awareness in the field of diabetes care and management. With a commitment to improving the quality of life for individuals affected by diabetes, the Foundation sponsors clinical trials aimed at exploring innovative treatment options, enhancing patient outcomes, and fostering collaboration among healthcare professionals. By leveraging a robust network of researchers, clinicians, and healthcare providers, the Diabetes Foundation strives to contribute to the global understanding of diabetes and to develop effective strategies for its prevention and management in the Indian context.

Locations

New Delhi, Delhi, India

Patients applied

0 patients applied

Trial Officials

Anoop Misra, MD

Principal Investigator

National Diabetes Obesity and Cholesterol Foundation

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported